Skip to main content
Clinical Trials/NCT05548478
NCT05548478RecruitingNot Applicable

Corneal Endothelial Cell Injury Induced by Mitomycin-C in TransEpi Single Step and Alcohol Assisted Photorefractive Keratectomy PRK: A Comparative Study

Al-Azhar University1 site in 1 country60 target enrollmentStarted: September 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
Endothelial cell Density

Study Overview

Brief Summary

our study will investigate the effecacy of Mitomycin-C in TransEpi single step photorefractive keratectomy (PRK) and alcohol assisted PRK

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
17 Years to 50 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age over 18 years.
  • •Primary myopia or compound myopic astigmatism.
  • •Preoperative manifest refraction spherical equivalent (MRSE) within the range of -1.0 to 8 D
  • •Stable refractive error for at least 12 months before the surgery.
  • •Contact lens discontinuation for at least 3 weeks.
  • •Estimated corneal stromal bed thickness of more than 300mm at the thinnest point

Exclusion Criteria

  • •Unwilling to participate in the study.
  • •Previous ocular surgery
  • •Any diagnosed ocular disease
  • •History of ocular trauma

Arms & Interventions

TransEpi single step PRK

Active Comparator

Intervention: Transepithelial PRK/MMC (Procedure)

alcohol assisted PRK

Active Comparator

Intervention: Alcohol-Assisted PRK/MMC (Procedure)

Outcomes

Primary Outcomes

Endothelial cell Density

Time Frame: at 3rd month

will be measured by Specular microscopy

Endothelial cell Density

Time Frame: Base line

will be measured by Specular microscopy

Endothelial cell Density

Time Frame: at 1st month

will be measured by Specular microscopy

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ehab tharwat

Dr

Al-Azhar University

Study Sites (1)

Loading locations...

Similar Trials